Heart failure affects 4% of the US population, yet treatment options are primarily symptomatic, including blood thinners, assistive devices and heart transplant. Patients today face a 50% 5-year survival rate upon diagnosis. It’s time to change that. Our approach is to engineer human cardiac orga...See more
Headquarter United States of America |
Countries of operation Australia, United States of America |
Funding status Private |
Company type SME |
Co-Founder and Scientific Advisor
Co-Founder
Co-Founder
Job title | Name | Email | Country based in | Job Function | Seniority | |
---|---|---|---|---|---|---|
Co-Founder and Scientific Advisor | hidden.item | hidden.item | hidden.item | |||
Co-Founder | hidden.item | hidden.item | hidden.item | |||
Co-Founder | hidden.item | hidden.item | hidden.item |